Trace Of Pollen Determines Source Of Counterfeit Anti-malaria Drug In China
This article was originally published in PharmAsia News
An investigation of counterfeit drugs in China exported to other countries disclosed a new method of determining the source of illegitimate ingredients. Guilin Pharmaceutical's anti-malaria drug based on the sweet wormwood plant was the target of counterfeiters. Investigators were able to trace particles of a type of pollen and calcite to a particular region of China. The counterfeits of the artesunate-based drug are of concern because they could lead to an artesunate-resistant form of malaria. (Click here for more
You may also be interested in...
Results of three-year study conducted at 17 Canadian sites suggest that e-cigarettes use combined with counseling significantly increased abstinence from smoking cigarettes compared to receiving counseling alone.
Cambridge Nutraceuticals - which develops dietary supplements that have “proven clinical benefits” - has snapped up UK-based Prime Fifty to enhance its offering with products specifically designed for the over 50s.
Shanghai Henlius Biotech has begun dosing in a Phase I trial for its HLX14 planned biosimilar version of denosumab. Multiple biosimilar developers are vying to take a slice of the market for rivals to Amgen’s Xgeva/Prolia original.